Bayer AG news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

BAYN 109.28 -1.88 (-1.69%)
price chart
Bayer Challenges India Compulsory License Ruling
German pharmaceutical company Bayer AG has formally lodged a challenge against a landmark Indian ruling that allowed a domestic generic drug-maker to produce a low-cost version of an anti-cancer drug for the Indian market.
Compulsory licensing sets off a wave of price cuts in cancer drugs  Livemint
Pesticide Profits or Bees: Bayer Responds
Last week I wrote a piece about the worrying phenomenon of Colony Collapse Disorder, a complicated problem that is decimating bee populations worldwide, and the theorized role of a a group of pesticides, the neonicotinoids, sold by the agrochemical ...
India's Generics-Big Pharma Battle Drops Drug Prices, Raises Legal Debate
The escalating battle between Big Pharma and India's generic drug manufacturers is pushing down medicine prices in one of the world's fastest growing pharmaceutical markets.
What Do the World's Most Powerful Pesticide Honchos Eat for Dinner?
I've made a career of sorts writing about the "big six" agrichemical companies—Monsanto, Dow, Bayer, DuPont, Syngenta, and BASF—that produce the great bulk of the world's pesticides and, increasingly, seeds.
U.S FDA advisers rebuff J&J/Bayer Xarelto heart drug
J&J developed the drug in partnership with German drugmaker Bayer AG. Xarelto is already approved for use to reduce the risk of blood clots in the legs and lungs of people who have had knee or hip replacement surgery.
FDA Panel Votes Against Expanded Use of Blood Thinner From Bayer, J&J
Xarelto, by Johnson & Johnson JNJ 0.31 % and Bayer AG BAYRY -1.27 % , is considered part of a new generation of blood-thinning drugs.
FDA Disapproves Xarelto Drug  TopNews New Zealand
Bayer CropScience Commits to Improving Wheat Varieties with Nebraska Breeding ...
In 2010, Bayer CropScience AG and the University of Nebraska-Lincoln signed a non-exclusive agreement to improve wheat breeding and generate new wheat varieties.
Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA ...
"With this agreement and upon marketing authorization, a newly formed Bayer Yakuhin ophthalmology field force and Santen, the leading ophthalmology company in Japan, will promote EYLEA," said Sebastian Guth, President & CEO of Bayer Yakuhin, Ltd.
Bayer, Onyx cancer drug fails in late-stage study
Bayer HealthCare is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of German pharmaceutical and chemicals firm Bayer AG. Onyx is based in South San Francisco, Calif. Lung cancer is the most common form of cancer ...
48th Annual Meeting of the American Society of Clinical Oncology (ASCO): Bayer ...
Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world's leading, innovative companies in the healthcare and medical products industry, ...